van Gulijk, Mandy
21  results:
Search for persons X
?
 
?
3

NKG2A is a late immune checkpoint on CD8 T cells and marks ..:

Borst, Linda ; Sluijter, Marjolein ; Sturm, Gregor...
International Journal of Cancer.  150 (2021)  4 - p. 688-704 , 2021
 
?
 
?
10

NKG2A is a late immune checkpoint on CD8 T cells and marks ..:

Borst, Linda ; Sluijter, Marjolein ; Sturm, Gregor...
Borst , L , Sluijter , M , Sturm , G , Charoentong , P , Santegoets , S J , van Gulijk , M , van Elsas , M J , Groeneveldt , C , van Montfoort , N , Finotello , F , Trajanoski , Z , Kiełbasa , S M , van der Burg , S H & van Hall , T 2022 , ' NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division ' , International Journal of Cancer , vol. 150 , no. 4 , pp. 688-704 . https://doi.org/10.1002/ijc.33859.  , 2022
 
?
12

Immune monitoring in mesothelioma patients identifies novel..:

Dammeijer, Floris ; Gooijer, CJ ; van Gulijk, Mandy...
Dammeijer , F , Gooijer , CJ , van Gulijk , M , Lukkes , M , Klaase , L , Lievense , S , Waasdorp , C , Jebbink , M , Bootsma , GP , Stigt , JA , Biesma , B , Lambers , M , Mankor , J , Vroman , H , Cornelissen , R , Baas , P , van der Noort , V , Burgers , JA & Aerts , J 2021 , ' Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response ' , EBioMedicine , vol. 64 , 103160 . https://doi.org/10.1016/j.ebiom.2020.103160.  , 2021
 
?
15

Dendritic cell vaccination and CD40-agonist combination the..:

Lau, Sai Ping ; Montfoort, Nadine ; Kinderman, P...
Lau , S P , Montfoort , N , Kinderman , P , Lukkes , M , Klaase , L , Nimwegen , M , Gulijk , M , Dumas , J , Mustafa , D , Lievense , SLA , Groeneveldt , C , Stadhouders , R , Li , YL , Stubbs , A , Marijt , KA , Vroman , H , van der Burg , SH , Aerts , J , van Hall , T , Dammeijer , F & Eijck , C 2020 , ' Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model ' , Journal for ImmunoTherapy of Cancer , vol. 8 , no. 2 , e000772 . https://doi.org/10.1136/jitc-2020-000772.  , 2020
 
1-15